HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: CTFA comments on VCRP

This article was originally published in The Rose Sheet

Executive Summary

CTFA comments on VCRP: Utility of FDA Voluntary Cosmetics Reporting Program "can be enhanced" by reinstating requirement for "semi-quantitative information on the amount of each ingredient used in a formulation," Cosmetic, Toiletry and Fragrance Association states in Oct. 2 comments responding to FDA's Aug. 29 Federal Register notice asking for input on VCRP usefulness ("The Rose Sheet" Sept. 2, p. 1). Based on "rapidly changing formulation opportunities with new ingredients" over the last few years and "a number of generic ingredient questions" that FDA is considering, semi-quantitative ingredient concentration formulation information "can be very valuable," CTFA asserts. Such data would also be useful to Cosmetic Ingredient Review's assessment of ingredient safety, and would make FDA data requirements consistent with those of the European Union, trade group adds...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003398

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel